Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease

In Vivo

Volumn 23, Issue 1, 2009, Pages 33-40

  Kolovou, Genovefa D ^a   Anagnostopoulou, Katherine K ^a   Kostakou, Peggy ^a   Giannakopoulou, Vassiliki ^a   Mihas, Constantinos ^b   Hatzigeorgiou, Georgios ^a   Vasiliadis, Ioannis K ^a   Mikhailidis, Dimitri P ^c   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b General Hospital of Kimi   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apolipoprotein E polymorphism; Coronary heart disease; Obesity

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; APOLIPOPROTEIN E GENE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PATIENT ASSESSMENT;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS E; BODY MASS INDEX; COMORBIDITY; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 63049091586     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kopelman PG: Obesity as a medical problem. Nature 404: 635-643, 2000.
2. Comuzzie AG and Allison DB: The search for human obesity genes. Science 280: 1374-1377, 1998.
3. Echwald SM: Genetics of human obesity: lessons from mouse models and candidate genes. J Intern Med 245: 653-656, 1999.
4. Pérusse L and Bouchard C: Genotype environment interaction in human obesity. Nutr Rev 57(5 Pt 2): S31-37, 1999.
5. Liu YJ, Araujo S, Recker RR and Deng HW: Molecular and genetic mechanisms of obesity: implications for future management. Curr Mol Med 3: 325-340, 2003.
6. Kolovou GD, Anagnostopoulou KK, Mikhailidis DP, Panagiotakos DB, Pilatis ND, Cariolou MA, Yiannakouris N, Degiannis D, Stavridis G and Cokkinos DV: Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men. Angiology 56: 663-670, 2005.
7. Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, Hatzigeorgiou G, Cariolou MA and Cokkinos DV: Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease. Curr Med Res Opin 18: 118-124, 2002.
8. Kolovou GD, Anagnostopoulou KK, Salpea KD, Panagiotakos DB, Hoursalas IS, Cariolou MA, Koniavitou K and Cokkinos DV: Apolipoprotein E genotype in matched men and women with coronary heart disease. Ann Clin Lab Sci 35: 391-396, 2005.
9. Kolovou G, Daskalova D and Mikhailidis DP: Apolipoprotein E polymorphism and atherosclerosis. Angiology 54: 59-71, 2003.
10. Kolovou GD, Daskalova DCh, Hatzivassiliou M, Yiannakouris N, Pilatis ND, Elisaf M, Mikhailidis DP, Cariolou MA and Cokkinos DV: The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population implications for the interpretation of similar studies. Angiology 54: 51-58, 2003.
11. Kolovou GD and Anagnostopoulou KK: Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev 6: 94-108, 2007.
12. Sing CF and Davignon J: Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268-285, 1985.
13. Boerwinkle E and Utermann G: Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42: 104-112, 1988.
14. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB and Cambien F: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14: 1412-1419, 1994.
15. Muros M and Rodríguez-Ferrer C: Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis 121: 13-21, 1996.
16. Braeckman L, De Bacquer D, Rosseneu M and De Backer G: Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoproteins. Atherosclerosis 120: 61-13, 1996.
17. Gylling H, Kontula K, Koivisto UM, Miettinen HE and Miettinen TA: Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 17: 38-44, 1997.
18. Gómez-Coronado D, Alvarez JJ, Entrala A, Olmos JM, Herrera E and Lasunción MA: Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins. Atherosclerosis 147: 167-176, 1999.
19. Kesäniemi YA, Ehnholm C and Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578-581, 1987.
20. Weintraub MS, Eisenberg S and Breslow JL: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80: 1571-1577, 1987.
21. Rubin J and Berglund L: Apolipoprotein E and diets: a case of gene-nutrient interaction? Curr Opin Lipidol 13: 25-32, 2002.
22. Erkkilä AT, Sarkkinen ES, Lindi V, Lehto S, Laakso M and Uusitupa MI: ApoE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am J Clin Nutr 73: 746-752, 2001.
23. Boer JM, Ehnholm C, Menzel HJ, Havekes LM, Rosseneu M, O'Reilly DS and Tiret L: Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 17: 1675-1681, 1997.
24. Ferrières J, Sing CF, Roy M, Davignon J and Lussier-Cacan S: Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects. Arterioscler Thromb 14: 1553-1560, 1994.
25. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S and Davignon J: The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 42: 895-901, 1993.
26. Watanabe J, Kobayashi K, Umeda F, Yamauchi T, Mimura K, Nakashima N, Masakado M, Hiramatsu S and Nawata H: Apolipoprotein E polymorphism affects the response to pravastatin on plasma apolipoproteins in diabetic patients. Diabetes Res Clin Pract 20: 21-27, 1993.
27. Pedro-Botet J, Schaefer EJ, Bakker-Arkema RG, Black DM, Stein EM, Corella D and Ordovas JM: Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis 158: 183-193, 2001.
28. Ordovas JM and Mooser V: The ApoE locus and the pharmacogenetics of lipid response. Curr Opin Lipidol 13: 113-117, 2002.
29. Leaman DM, Brower RW, Meester GT, Serruys P and van den Brand M: Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 63: 285-299, 1981.
30. WHO Prevention and Management of the Global Epidemic of Obesity. Report of the WHO Consultation on Obesity. WHO. Geneva. Press Release WHO/46, 1997.
31. Davignon J, Greeg RE and Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21, 1988.
32. Nieminen MS, Mattila KJ, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, Ehnholm C, Jauhiainen M, Valle M and Taskinen MR: Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb 12: 58-69, 1992.
33. Hixson JE and Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb 11: 1237-1244, 1991.
34. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA and Schaefer EJ: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA 272: 1666-1671, 1994.
35. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V and Havekes LM: Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations: the EARS Study. Arterioscler Thromb 14: 1617-1624, 1994.
36. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE and Neaton JD: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71: 160-165, 1993.
37. van Bockxmeer FM and Mamotte CD: Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 340: 878-880, 1992.
38. Wilson PW, Schaefer EJ, Larson MG and Ordovas JM: Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16: 1250-1255, 1996.
39. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, Parpos S, Pedro-Botet J, Daly JA and Ordovas JM: Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154: 529-537, 2001.
40. Kolovou GD, Anagnostopoulou KK and Cokkinos DV: Apolipoprotein E gene polymorphism and myocardial infarction. Int J Cardiol, 2008 (in press).
41. Ordovas JM: The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc 58: 171-187, 1999.
42. Aguilar CA, Talavera G, Ordovas JM, Barriguete JA, Guillén LE, Leco ME, Pedro-Botet J, Gonzalez-Barranco J, Gómez-Pérez FJ and Rull JA: The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle. Atherosclerosis 142: 409-414, 1999.
43. Dallongeville J, Tiret L, Visvikis S, O'Reilly DS, Saava M, Tsitouris G, Rosseneu M, DeBacker G, Humphries SE and Beisiegel U: Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study. Atherosclerosis 145: 381-388, 1999.
44. Song Y, Stampfer MJ and Liu S: Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141: 137-147, 2004.
45. Hixson JE and Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548, 1990.
46. Gajra B, Candlish JK, Saha N, Heng CK, Soemantri AG and Tay JSH: Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population. Genet Epidemiol 11: 19-27, 1994.
47. Gajra B, Candlish JK, Saha N, Mak JW and Tay JSH: Effect of apolipoprotein E variants on plasma lipids and apolipoproteins in the Orang Asli ('Aborigines') of Malaysia. Hum Hered 44: 209-213, 1994.
48. Reilly SL, Ferrell RE and Sing CF: The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minn, III: correlations and covariances. Am J Hum Genet 55: 1001-1018, 1994.
49. Xu CF, Talmud PJ, Angelico F, Ben MD, Savill J and Humphries SE: Apolipoprotein E polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children. Genet Epidemiol 8: 389-398, 1991.
50. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 285: 2486-2509, 2001.